Presentations made by the invited speakers at the Forum Event 2009
Opening session of The Forum event of Forinvitox and Invitopharma
Erica Toft , Silverdal Science Park, Sweden
Summary of the Forinvitox project 
Erica Toft.pdf (211,4 kB)
Antek Wielburski, Expertrådet, Sweden
Summary of the Invitopharma project Antek Wielburski.pdf (73,5 kB)
Session 1: Available in vitro methods with potential to be commercialised
Oliver Engelking, CellSystems® Biotechnologie Vertrieb GmbH, Germany
Human Reconstructed Skin - a success story Oliver Engelking.pdf (980,4 kB)
Session 2: Testing needs and expectation - managed by IVTIP
Bart De Wever and Erwin Roggen, IVTIP In Vitro Testing Industrial Platform, Belgium
Testing needs and expectations: the importance of industrial applicability Bart De Wever.pdf (200,9 kB)
Klaus Schroeder , Henkel AG & Co, Germany
The application of the 7th amendment: what models for what use? Klaus Schroeder.pdf (625,2 kB)
Gavin Maxwell, Unilever, UK
Assuring safety without animal testing: Skin sensitisation case study Gavin Maxwell.pdf (4558,3 kB)
Session 3: Acceptance and validation - The regulators point of view
Matthias Peiser, Federal Institute for Risk Assessment, Germany
Even alternative methods regarded "stand alone" replacements of animal tests need to be embedded in testing strategies - a regulators view Matthias Peiser.pdf(1561,6 kB)
Session 4: Technology transfer
Leila Risteli, University of Oulu, Finland
What to consider in academic technology transfer Leila Risteli.pdf (207,0 kB)
Claes Post, Karolinska Institutet Innovation, Sweden Claes Post.pdf (1201,1 kB)
Session 5: Quality and scientific acceptance of alternative methods
Sandra Coecke, ECVAM, Italy
Towards relevant and reliable in vitro cell-based test methods for detecting human health effects Sandra Coecke.pdf (1105,7 kB)
Rodger D. Curren, IIVS, Institute for In Vitro Sciences, USA
Human tissue models used for safety testing: scientific, economic and regulatory considerations Rodger Curren - Human tissue models.pdf (622,3 kB)
Discussion around points to consider when moving towards acceptance, initiated byErin H. Hill, Institute for In Vitro Sciences, USA Erin Hill.pdf (189,1 kB)
